Pier Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4M | Sell |
314,796
-20,708
| -6% | -$290K | 0.67% | 73 |
|
|
2025
Q1 | $4.56M | Buy |
335,504
+3,185
| +1% | +$43.3K | 0.76% | 65 |
|
|
2024
Q4 | $6.77M | Buy |
332,319
+164,237
| +98% | +$3.35M | 0.97% | 66 |
|
|
2024
Q3 | $4.9M | Buy |
168,082
+2,596
| +2% | +$75.6K | 0.69% | 81 |
|
|
2024
Q2 | $3.84M | Sell |
165,486
-6,845
| -4% | -$159K | 0.57% | 86 |
|
|
2024
Q1 | $3.54M | Sell |
172,331
-1,888
| -1% | -$38.7K | 0.49% | 89 |
|
|
2023
Q4 | $3.74M | Buy |
174,219
+49,139
| +39% | +$1.05M | 0.53% | 87 |
|
|
2023
Q3 | $2.58M | Sell |
125,080
-2,048
| -2% | -$42.3K | 0.42% | 91 |
|
|
2023
Q2 | $3.75M | Buy |
+127,128
| New | +$3.75M | 0.54% | 89 |
|